İ. SELÇUK Et Al. , "Oocyte Triggering in Overweight and Obese Patients Undergo ICSI: 250 μg Versus 500 μg Recombinant Hcg," EGE KLİNİKLERİ TIP DERGİSİ , vol.58, no.2, pp.144-149, 2020
SELÇUK, İ. Et Al. 2020. Oocyte Triggering in Overweight and Obese Patients Undergo ICSI: 250 μg Versus 500 μg Recombinant Hcg. EGE KLİNİKLERİ TIP DERGİSİ , vol.58, no.2 , 144-149.
SELÇUK, İ., BOYRAZ, G., BOZDAĞ, G., KARAKOÇ SÖKMENSÜER, L., & ESİNLER, İ., (2020). Oocyte Triggering in Overweight and Obese Patients Undergo ICSI: 250 μg Versus 500 μg Recombinant Hcg. EGE KLİNİKLERİ TIP DERGİSİ , vol.58, no.2, 144-149.
SELÇUK, İLKER Et Al. "Oocyte Triggering in Overweight and Obese Patients Undergo ICSI: 250 μg Versus 500 μg Recombinant Hcg," EGE KLİNİKLERİ TIP DERGİSİ , vol.58, no.2, 144-149, 2020
SELÇUK, İLKER Et Al. "Oocyte Triggering in Overweight and Obese Patients Undergo ICSI: 250 μg Versus 500 μg Recombinant Hcg." EGE KLİNİKLERİ TIP DERGİSİ , vol.58, no.2, pp.144-149, 2020
SELÇUK, İ. Et Al. (2020) . "Oocyte Triggering in Overweight and Obese Patients Undergo ICSI: 250 μg Versus 500 μg Recombinant Hcg." EGE KLİNİKLERİ TIP DERGİSİ , vol.58, no.2, pp.144-149.
@article{article, author={İLKER SELÇUK Et Al. }, title={Oocyte Triggering in Overweight and Obese Patients Undergo ICSI: 250 μg Versus 500 μg Recombinant Hcg}, journal={EGE KLİNİKLERİ TIP DERGİSİ}, year=2020, pages={144-149} }